U.S. market Closed. Opens in 17 hours 17 minutes

CORT | Corcept Therapeutics Incorporated Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for CORT we got that it has strong fundamentals where Valuation is considered to be slightly undervalued, Profitability is stunning wealthy, Growth is good and Health is strong.

Valuation (62%)

Company Industry
P/E Ratio (TTM) 31.19 -15.40
PEG Ratio (TTM) 3.30 -1.28
P/S Ratio (TTM) 6.99 47.91
P/B Ratio (TTM) 6.59 21.47
P/FCF Ratio (TTM) 32.30 5.35
Price to 5YR AVG Earnings Ratio 40.63 -0.30
Price to 5YR AVG FCF Ratio 28.44 -7.28

Profitability (90%)

Company Industry
ROA (TTM) 17.63% -2.96%
ROE (TTM) 23.86% 23.42%
Net Profit Margin (TTM) 22.12% -894.56%
ROIC 5YR AVG 99.61% 16.62%

Growth (70%)

4QTR AVG 3YR AVG 5YR AVG
EPS 6.88% 14.60% 9.82%
Revenue 8.64% 13.62% 14.14%
Net Income 7.57% 14.53% 7.68%
Cash Flow 78.28% 13.27% 3.41%

Health (68%)

Company Industry
Current Ratio (TTM) 5.57 5.73
Quick Ratio (TTM) 5.48 5.45
D/E Ratio (TTM) 0.01 -14.53
Interest Coverage (TTM) 35.73 3.88
Piotroski F-Score 7 5
Altman Z-Score 23.39 13.58
LTL to 5YR AVG FCF N/A 0.21
Shares Outstanding Growth 5YR AVG -2.08% 117.96%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙